- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04603950
IPICK Blocking for TKA With Moderate Flexion Contracture
July 22, 2022 updated by: The First Hospital of Jilin University
IPICK Blocking for Extension Recovery in TKA With Preoperative Moderate Flexion Contracture
Clinical effect of intermittent multiple IPICK blocking on TKA for knee osteoarthritis with flexion contracture between 5 ° and 10 °
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
From October 2020 to January 2021, 40 knee osteoarthritis patients with flexion contracture between 5 ° and 10 ° total knee arthroplasty are enrolled in this study.
20 patients are treated with Adductor Canal Block + Infiltration between the Popliteal Artery and Capsule of the Knee, and 20 patients are treated with Adductor Canal Block alone.
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Changchun, China
- The First Hospital of Jilin University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The diagnosis was knee osteoarthritis
- The flexion contracture was between 5 and 10 degrees
- ASA grade I-III
Exclusion Criteria:
- Lower extremity neuropathy.
- Contraindications of nerve anesthesia or regional anesthesia.
- unable to cooperate, allergic to the drugs used in this study.
- Non steroidal anti-inflammatory drugs are not tolerated.
- chronic opioid consumption (daily or almost daily use)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: study group
The first 20 patients received Continue Adductor Canal Block + Infiltration between the Popliteal Artery and Capsule of the Knee
|
continue adductor canal block plus Infiltration between the Popliteal Artery and Capsule of the Knee
|
Sham Comparator: control group
The second 20 patients received Continue Adductor Canal Block alone
|
continue adductor canal block
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
evaluation of pain
Time Frame: 6 hours after surgery
|
Visual Analog Score for pain at rest, straightening, flexion at 45 ° and walking, the minimum and maximum values are 0 to 10, higher scores mean a worse outcome.
|
6 hours after surgery
|
evaluation of pain
Time Frame: postoperative day 1
|
Visual Analog Score for pain at rest, straightening, flexion at 45 ° and walking, the minimum and maximum values are 0 to 10, higher scores mean a worse outcome.
|
postoperative day 1
|
evaluation of pain
Time Frame: postoperative day 2
|
Visual Analog Score for pain at rest, straightening, flexion at 45 ° and walking, the minimum and maximum values are 0 to 10, higher scores mean a worse outcome.
|
postoperative day 2
|
evaluation of pain
Time Frame: postoperative day 3
|
Visual Analog Score for pain at rest, straightening, flexion at 45 ° and walking, the minimum and maximum values are 0 to 10, higher scores mean a worse outcome.
|
postoperative day 3
|
extension angle
Time Frame: before surgery
|
degree of the extension of knee
|
before surgery
|
extension angle
Time Frame: 0 hour after surgery
|
degree of the extension of knee
|
0 hour after surgery
|
extension angle
Time Frame: 6 hour after surgery
|
degree of the extension of knee
|
6 hour after surgery
|
extension angle
Time Frame: postoperative day 1
|
degree of the extension of knee
|
postoperative day 1
|
extension angle
Time Frame: postoperative day 2
|
degree of the extension of knee
|
postoperative day 2
|
extension angle
Time Frame: postoperative day 3
|
degree of the extension of knee
|
postoperative day 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
range of motion
Time Frame: 6 hour after surgery
|
degree of range of motion from extension to flexion of knee
|
6 hour after surgery
|
range of motion
Time Frame: postoperative day 1
|
degree of range of motion from extension to flexion of knee
|
postoperative day 1
|
range of motion
Time Frame: postoperative day 2
|
degree of range of motion from extension to flexion of knee
|
postoperative day 2
|
range of motion
Time Frame: postoperative day 3
|
degree of range of motion from extension to flexion of knee
|
postoperative day 3
|
opioid consumption
Time Frame: through hospitalization, an average of 7 days
|
total opioid consumption measured by milliliter.
|
through hospitalization, an average of 7 days
|
nerve block related symptoms
Time Frame: through hospitalization, an average of 7 days
|
the incidence of numbness of the nerve related skin
|
through hospitalization, an average of 7 days
|
postoperative acute pain
Time Frame: through hospitalization, an average of 7 days
|
number of cases whose Visual Analog Score for pain was more than 5
|
through hospitalization, an average of 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Actual)
February 28, 2021
Study Completion (Actual)
March 31, 2021
Study Registration Dates
First Submitted
October 8, 2020
First Submitted That Met QC Criteria
October 26, 2020
First Posted (Actual)
October 27, 2020
Study Record Updates
Last Update Posted (Actual)
July 26, 2022
Last Update Submitted That Met QC Criteria
July 22, 2022
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- QiXin2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on CACB+IPACK
-
Prof. Dr. Cemil Tascıoglu Education and Research...Completed
-
Luzerner KantonsspitalRecruitingJoint Diseases | Joint PainSwitzerland
-
Ziekenhuis Oost-LimburgCompletedAnalgesia | Total Knee ArthroplastyBelgium
-
University of TorontoMOUNT SINAI HOSPITALRecruitingAcute Pain | Knee Arthroplasty, Total | Anesthesia, RegionalCanada
-
NYU Langone HealthCompletedAnterior Cruciate Ligament RuptureUnited States
-
Tanta UniversityCompleted
-
Ain Shams UniversityEnrolling by invitation
-
University Tunis El ManarInstitut Kassab d'OrthopédieCompleted
-
Centre Hospitalier Universitaire VaudoisRecruiting
-
Centre Hospitalier Universitaire VaudoisRecruitingPostoperative Pain | Analgesia | Arthropathy of KneeSwitzerland